how long have glp 1 drugs been around The expanding landscape of GLP-1 medicines What are GLP-1s? | Mendinground
Description
17 In addition to these findings, the SUSTAIN-6 trial also showed that semaglutide can offer a significant reduction in the risk of new or worsening nephropathy including persistent macroalbuminuria, increase in serum creatinine or the need of renal replacement therapy
Diabetologia (2017) 60:144253
Post-approval Exclusivities Drug manufacturers listed 22 patents after FDA approval of the 10 products in the cohort (median 1.5 [IQR: 02.8]), including 11 patents on devices (50%)
They treat type 2 diabetes, aid weight loss, and may improve cardiovascular health
Holz, G
Understanding GIP: The Second Incretin GIP received less attention initially than GLP-1 because early research suggested it might not be useful for diabetes treatment
